Raltegravir-induced cerebellar ataxiaREISS, Kim A; BAILEY, Justin R; PHAM, Paul A et al.AIDS (London). 2010, Vol 24, Num 17, issn 0269-9370, p. 2757Article

Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimenROQUEBERT, Benedicte; BLUM, Laurent; COLLIN, Gilles et al.AIDS (London). 2008, Vol 22, Num 15, pp 2045-2046, issn 0269-9370, 2 p.Article

Divalent Metals and pH Alter Raltegravir Disposition In VitroMOSS, Darren M; SICCARDI, Marco; MURPHY, Matthew et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 6, pp 3020-3026, issn 0066-4804, 7 p.Article

Pharmacokinetic Modeling of Plasma and Intracellular Concentrations of Raltegravir in Healthy VolunteersLINGZHI WANG; GAIK HONG SOON; SENG, Kok-Yong et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 9, pp 4090-4095, issn 0066-4804, 6 p.Article

Characterization of Binding of Raltegravir to Plasma ProteinsBARAU, Caroline; FURLAN, Valérie; YAZDANPANAH, Yazdan et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 10, pp 5147-5150, issn 0066-4804, 4 p.Article

Assessment of the pharmacokinetics of co-administered maraviroc and raltegravirANDREWS, Emma; GLUE, Paul; JUANZHI FANG et al.British journal of clinical pharmacology. 2010, Vol 69, Num 1, pp 51-57, issn 0306-5251, 7 p.Article

Next-Generation Integrase Inhibitors: Where to After Raltegravir?KARMON, Sharon L.Drugs (Basel). 2013, Vol 73, Num 3, pp 213-228, issn 0012-6667, 16 p.Article

Raltegravir central nervous system tolerability in clinical practice: results from a multicenter observational studyMADEDDU, Giordano; MENZAGHI, Barbara; RICCI, Elena et al.AIDS (London). 2012, Vol 26, Num 18, pp 2412-2415, issn 0269-9370, 4 p.Article

Pharmacokinetics of Raltegravir in Individuals With UGT1 A1 PolymorphismsWENNING, L. A; POETRY, A. S; LUNDE, N. M et al.Clinical pharmacology and therapeutics. 2009, Vol 85, Num 6, pp 623-627, issn 0009-9236, 5 p.Article

Update on Raltegravir and the Development of New Integrase Strand Transfer InhibitorsLEE SHAMROE, Caitlin; BOOKSTAVER, Paul Brandon; ROKAS, Kristina E. E et al.Southern medical journal (Birmingham, Ala. Print). 2012, Vol 105, Num 7, pp 370-378, issn 0038-4348, 9 p.Article

Effect of continuous venovenous hemodiafiltration on darunavir and raltegravir exposure after administration via a gastroduodenal tubeTAEGTMEYER, Anne B; MÜLLER, Veronique; KOVARI, Helen et al.AIDS (London). 2011, Vol 25, Num 10, pp 1339-1341, issn 0269-9370, 3 p.Article

Cross-resistance Profile of the Novel Integrase Inhibitor Dolutegravir (S/GSK1349572) Using Clonal Viral Variants Selected in Patients Failing RaltegravirCANDUCCI, Filippo; CERESOLA, Elisa R; BOERI, Enzo et al.The Journal of infectious diseases. 2011, Vol 204, Num 11, pp 1811-1815, issn 0022-1899, 5 p.Article

Raltegravir Penetration in Seminal Plasma of Healthy VolunteersCALCAGNO, Andrea; BONORA, Stefano; D'AVOLIO, Antonio et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 6, pp 2744-2745, issn 0066-4804, 2 p.Article

Les différentes classes de molécules inhibant l'intégrase du VIH1 = The different classes of HIV integrase inhibitorsCOTELLE, P; QUEFFELEC, C.Virologie (Montrouge). 2007, Vol 11, Num DEC, issn 1267-8694, S163-S173, NSArticle

Three Distinct Phases of HIV-1 RNA Decay in Treatment-Naive Patients Receiving Raltegravir-Based Antiretroviral Therapy: ACTG A5248ANDRADE, Adriana; ROSENKRANZ, Susan L; FLEXNER, Charles et al.The Journal of infectious diseases. 2013, Vol 208, Num 6, pp 884-891, issn 0022-1899, 8 p.Article

Short-Course Raltegravir Intensification Does Not Increase 2 Long Terminal Repeat Episomal HIV-1 DNA in Patients on Effective Antiretroviral TherapyBESSON, Guillaume J; MCMAHON, Deborah; MALDARELLI, Frank et al.Clinical infectious diseases. 2012, Vol 54, Num 3, pp 451-453, issn 1058-4838, 3 p.Article

Long-lasting persistence of integrase resistance mutations in HIV-2-infected patients after raltegravir withdrawalCHARPENTIER, Charlotte; LARROUY, Lucile; MATHERON, Sophie et al.Antiviral therapy (London). 2011, Vol 16, Num 6, pp 937-940, issn 1359-6535, 4 p.Article

Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patientsCABY, Fabienne; VALIN, Nadia; PACANOWSKI, Jérome et al.Scandinavian journal of infectious diseases. 2010, Vol 42, Num 6-7, pp 527-532, issn 0036-5548, 6 p.Article

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trialsERON, Joseph J; COOPER, David A; LOUTFY, Mona R et al.Lancet. Infectious diseases (print). 2013, Vol 13, Num 7, pp 587-596, issn 1473-3099, 10 p.Article

Raltegravir In Vitro Effect on Bilirubin BindingCLARKE, Diana F; WONG, Ronald J; WENNING, Larissa et al.The Pediatric infectious disease journal. 2013, Vol 32, Num 9, pp 978-980, issn 0891-3668, 3 p.Article

Pharmacokinetics of and Short-Term Virologic Response to Low-Dose 400-Milligram Once-Daily Raltegravir Maintenance TherapyANANWORANICH, Jintanat; GOROWARA, Meena; AVIHINGSANON, Anchalee et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 4, pp 1892-1898, issn 0066-4804, 7 p.Article

Effect of raltegravir on the total and unintegrated proviral HIV DNA during raltegravir-based HAARTNICASTRI, Emanuele; TOMMASI, Chiara; AMENDOLA, Alessandro et al.Antiviral therapy (London). 2011, Vol 16, Num 6, pp 797-803, issn 1359-6535, 7 p.Article

The SnoB study: frequency of baseline raltegravir resistance mutations prevalence in different non-B subtypesSIERRA, Saleta; LÜBKE, Nadine; WALTER, Hauke et al.Medical microbiology and immunology. 2011, Vol 200, Num 4, pp 225-232, issn 0300-8584, 8 p.Article

Sustained virological response to a raltegravir-containing salvage therapy in an HIV-2-infected patientWANDELER, Gilles; FURRE, Hansjakob; RAUNCH, Andri et al.AIDS (London). 2011, Vol 25, Num 18, pp 2306-2308, issn 0269-9370, 3 p.Article

Pharmacokinetics of double-dose raltegravir in two patients with HIV infection and tuberculosisBURGER, David M; MAGIS-ESCURRA, Cecile; VAN DEN BERK, Guido E. L et al.AIDS (London). 2010, Vol 24, Num 2, pp 328-330, issn 0269-9370, 3 p.Article